Vincenzo Esposito

Head of Immunodeficiencies and Gender related Infectious Diseases

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vincenzo Esposito is the Head of Immunodeficiencies and Gender Related Infectious Diseases at AORN Ospedali dei Colli in Italy. His research primarily focuses on the intersection of infectious diseases and immunodeficiencies, with recent publications addressing topics such as the role of dalbavancin in treating Gram-positive infections during the COVID-19 pandemic, and the effects of chronic liver disease on COVID-19 outcomes. Other research areas include the dynamics of T lymphocyte responses in HIV/HCV co-infection and the therapeutic potential of intravenous immunoglobulin for SARS-CoV-2 related complications.

Articles (10)

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

PAOLO GROSSI

PROFESSORE DI I FASCIA

Università degli Studi di Roma La Sapienza

ITALY

View details

Fabio Porru

Erasmus University Rotterdam

NETHERLANDS

View details

VALENTINA SVICHER

University of Rome Tor Vergata

ITALY

View details

Francesca Ceccherini-Silberstein

University of Rome Tor Vergata

ITALY

View details

Roberta Petrino

Head of department

Ospedale regionale di Lugano

SWITZERLAND

View details

ANDREA COSTANTINI

Assistant Professor of Clinical Immunology

Università Politecnica delle Marche

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vincenzo Esposito

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The impact of DAA-mediated HCV eradication on CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort.

The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives

HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients.

Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO).

Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study.

SARS-CoV-2 and inflammatory responses: From mechanisms to the potential therapeutic use of intravenous immunoglobulin.

Persons living with HIV may be reluctant to access to COVID-19 testing services: data from 'D. Cotugno' Hospital, Naples, Southern Italy.

Current trends in the real-life use of dalbavancin: report of a study panel.

Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better.

COVID-19 among healthcare workers in a specialist infectious diseases setting in Naples, Southern Italy: results of a cross-sectional surveillance study.

Collaborators (6)

PAOLO GROSSI

Fabio Porru

VALENTINA SVICHER

Francesca Ceccherini-Silberstein

Roberta Petrino

ANDREA COSTANTINI

Make your next move.